BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21109168)

  • 1. Global spread of New Delhi metallo-β-lactamase 1.
    Koh TH; Khoo CT; Wijaya L; Leong HN; Lo YL; Lim LC; Koh TY
    Lancet Infect Dis; 2010 Dec; 10(12):828. PubMed ID: 21109168
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of a novel variant NDM-10, of the New Delhi metallo-beta-lactamase in a Klebsiella pneumoniae isolate.
    Khajuria A; Praharaj AK; Kumar M; Grover N
    Indian J Med Microbiol; 2016; 34(1):121-3. PubMed ID: 26776144
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, July 2011.
    McDermott H; Morris D; McArdle E; O'Mahony G; Kelly S; Cormican M; Cunney R
    Euro Surveill; 2012 Feb; 17(7):. PubMed ID: 22370013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
    Hasman H; Fjeldsøe-Nielsen H; Lausten T; Berthelsen BG
    Int J Antimicrob Agents; 2010 Nov; 36(5):468-9. PubMed ID: 20724117
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China.
    Wang X; Li H; Zhao C; Chen H; Liu J; Wang Z; Wang Q; Zhang Y; He W; Zhang F; Wang H
    Int J Antimicrob Agents; 2014 Jul; 44(1):90-1. PubMed ID: 24913967
    [No Abstract]   [Full Text] [Related]  

  • 6. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?
    Bonomo RA
    Clin Infect Dis; 2011 Feb; 52(4):485-7. PubMed ID: 21258101
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
    Poulou A; Spanakis N; Pournaras S; Pitiriga V; Ranellou K; Markou F; Tsakris A
    J Antimicrob Chemother; 2010 Dec; 65(12):2538-42. PubMed ID: 20876622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global spread of New Delhi metallo-β-lactamase 1.
    Hammerum AM; Toleman MA; Hansen F; Kristensen B; Lester CH; Walsh TR; Fuursted K
    Lancet Infect Dis; 2010 Dec; 10(12):829-30. PubMed ID: 21109169
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
    Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
    J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
    Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
    J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
    [No Abstract]   [Full Text] [Related]  

  • 12. SHV-5 extended-spectrum beta-lactamase from Klebsiella pneumoniae associated with a nosocomial outbreak in a paediatric oncology unit in Malaysia.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Int J Infect Dis; 2005 May; 9(3):170-2. PubMed ID: 15840458
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmid-mediated carbapenem-hydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia.
    Cuzon G; Naas T; Lesenne A; Benhamou M; Nordmann P
    Int J Antimicrob Agents; 2010 Jul; 36(1):91-3. PubMed ID: 20356714
    [No Abstract]   [Full Text] [Related]  

  • 14. New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae, Florida, USA(1).
    Li JJ; Munoz-Price LS; Spychala CN; DePascale D; Doi Y
    Emerg Infect Dis; 2016 Apr; 22(4):744-6. PubMed ID: 26983001
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
    Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS
    J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait.
    Jamal W; Rotimi VO; Albert MJ; Khodakhast F; Udo EE; Poirel L
    Int J Antimicrob Agents; 2012 Feb; 39(2):183-4. PubMed ID: 22113192
    [No Abstract]   [Full Text] [Related]  

  • 17. Emergence of KPC-producing Klebsiella pneumoniae in Texas.
    Hirsch EB; Chang KT; Lasco TM; Caeiro JP; Tam VH
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):234-5. PubMed ID: 21251574
    [No Abstract]   [Full Text] [Related]  

  • 18. Global spread of New Delhi metallo-β-lactamase 1.
    Poirel L; Hombrouck-Alet C; Freneaux C; Bernabeu S; Nordmann P
    Lancet Infect Dis; 2010 Dec; 10(12):832. PubMed ID: 21109172
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissemination of multidrug-resistant Klebsiella pneumoniae clinical isolates with various combinations of carbapenemases (NDM-1 and OXA-72) and 16S rRNA methylases (ArmA, RmtC and RmtF) in Nepal.
    Tada T; Miyoshi-Akiyama T; Dahal RK; Mishra SK; Ohara H; Shimada K; Kirikae T; Pokhrel BM
    Int J Antimicrob Agents; 2013 Oct; 42(4):372-4. PubMed ID: 23978353
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
    Gomez S; Pasteran F; Faccone D; Bettiol M; Veliz O; De Belder D; Rapoport M; Gatti B; Petroni A; Corso A
    Clin Microbiol Infect; 2013 May; 19(5):E233-5. PubMed ID: 23402333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.